{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:24:38Z","timestamp":1790871878720,"version":"4.1.0"},"reference-count":38,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6,1]]},"DOI":"10.1210\/jc.2013-4232","type":"journal-article","created":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T15:28:21Z","timestamp":1394810901000},"page":"E999-E1006","source":"Crossref","is-referenced-by-count":46,"title":["Glycation of the Complement Regulatory Protein CD59 Is a Novel Biomarker for Glucose Handling in Humans"],"prefix":"10.1210","volume":"99","author":[{"given":"Pamela","family":"Ghosh","sequence":"first","affiliation":[{"name":"Division of Hematology (P.G., R.S., M.C., J.A.H.), Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Vaidya","sequence":"additional","affiliation":[{"name":"Department of Medicine, and Division of Endocrinology, Diabetes, and Hypertension (A.V.), Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupam","family":"Sahoo","sequence":"additional","affiliation":[{"name":"Division of Hematology (P.G., R.S., M.C., J.A.H.), Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Goldfine","sequence":"additional","affiliation":[{"name":"Joslin Diabetes Center (A.G.), Harvard Medical School, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Herring","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital, Harvard Medical School, and Crimson Biospecimen Core (N.H., L.B.), Partners Healthcare System, Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Bry","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital, Harvard Medical School, and Crimson Biospecimen Core (N.H., L.B.), Partners Healthcare System, Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chorev","sequence":"additional","affiliation":[{"name":"Division of Hematology (P.G., R.S., M.C., J.A.H.), Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Halperin","sequence":"additional","affiliation":[{"name":"Division of Hematology (P.G., R.S., M.C., J.A.H.), Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113390873700_B1","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1073\/pnas.97.10.5450","article-title":"Molecular basis for a link between complement and the vascular complications of diabetes","volume":"97","author":"Acosta","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2019041113390873700_B2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/PL00007406","article-title":"Local activation of the complement system in endoneurial mi,crovessels of diabetic neuropathy","volume":"99","author":"Rosoklija","year":"2000","journal-title":"Acta Neuropathol (Berl)"},{"key":"key\n\t\t\t\t2019041113390873700_B3","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.2337\/diabetes.51.12.3499","article-title":"Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy","volume":"51","author":"Zhang","year":"2002","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113390873700_B4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nrendo.2009.266","article-title":"Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily","volume":"6","author":"Flyvbjerg","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"key\n\t\t\t\t2019041113390873700_B5","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00125-010-1742-8","article-title":"Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes","volume":"53","author":"Hansen","year":"2010","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113390873700_B6","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.2337\/diabetes.54.5.1523","article-title":"Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort study","volume":"54","author":"Hovind","year":"2005","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113390873700_B7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1053\/j.ajkd.2004.04.027","article-title":"Possible mechanism for medial smooth muscle cell injury in diabetic nephropathy: glycoxidation-mediated local complement activation","volume":"44","author":"Uesugi","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t2019041113390873700_B8","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.2337\/db10-1181","article-title":"Transcriptome analysis of human diabetic kidney disease","volume":"60","author":"Woroniecka","year":"2011","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113390873700_B9","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/BF03401659","article-title":"The transient pore formed by homologous terminal complement complexes functions as a bidirectional route for the transport of autocrine and paracrine signals across human cell membranes","volume":"2","author":"Acosta","year":"1996","journal-title":"Mol Med"},{"key":"key\n\t\t\t\t2019041113390873700_B10","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2337\/diabetes.53.10.2653","article-title":"Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes","volume":"53","author":"Qin","year":"2004","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113390873700_B11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1084\/jem.179.3.985","article-title":"Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells","volume":"179","author":"Benzaquen","year":"1994","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t2019041113390873700_B12","first-page":"1","article-title":"Human protectin (CD59), an 18,000\u201320,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers","volume":"71","author":"Meri","year":"1990","journal-title":"Immunology"},{"key":"key\n\t\t\t\t2019041113390873700_B13","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1182\/blood.V76.12.2572.2572","article-title":"Regulatory control of the terminal complement proteins at the surface of human endothelial cells: neutralization of a C5b-9 inhibitor by antibody to CD59","volume":"76","author":"Hamilton","year":"1990","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019041113390873700_B14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1074-7613(03)00022-0","article-title":"Deficiency of the mouse complement regulatory protein mCd59b results in spontaneous hemolytic anemia with platelet activation and progressive male infertility","volume":"18","author":"Qin","year":"2003","journal-title":"Immunity"},{"key":"key\n\t\t\t\t2019041113390873700_B15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCRESAHA.108.191361","article-title":"Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complex","volume":"104","author":"Wu","year":"2009","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t2019041113390873700_B16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/(SICI)1096-8652(199911)62:3<175::AID-AJH7>3.0.CO;2-8","article-title":"Paroxysmal nocturnal hemoglobinuria: An acquired genetic disease","volume":"62","author":"Nishimura","year":"1999","journal-title":"Am J Hematol"},{"key":"key\n\t\t\t\t2019041113390873700_B17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2174\/1381612043453441","article-title":"Complement and complement regulatory proteins as potential molecular targets for vascular diseases","volume":"10","author":"Acosta","year":"2004","journal-title":"Curr Pharm Des"},{"key":"key\n\t\t\t\t2019041113390873700_B18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.imlet.2003.07.001","article-title":"Determination of CD59 protein in normal human serum by enzyme immunoassay, using octyl-glucoside detergent to release glycosyl-phosphatidylinositol-CD59 from lipid complex","volume":"90","author":"Landi","year":"2003","journal-title":"Immunol Lett"},{"key":"key\n\t\t\t\t2019041113390873700_B19","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1182\/blood-2008-04-154112","article-title":"Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c","volume":"112","author":"Cohen","year":"2008","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019041113390873700_B20","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/ajh.23478","article-title":"A specific and sensitive assay for blood levels of glycated CD59: A novel biomarker for diabetes","volume":"88","author":"Ghosh","year":"2013","journal-title":"Am J Hematol"},{"key":"key\n\t\t\t\t2019041113390873700_B21","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1101\/gr.094615.109","article-title":"Instrumenting the health care enterprise for discovery research in the genomic era","volume":"19","author":"Murphy","year":"2009","journal-title":"Genome Res"},{"key":"key\n\t\t\t\t2019041113390873700_B22","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2337\/dc11-1642","article-title":"Complement activation and prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial","volume":"35","author":"Mellbin","year":"2012","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113390873700_B23","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.2337\/diabetes.53.6.1570","article-title":"Association between mannose-binding lectin and vascular complications in type 1 diabetes","volume":"53","author":"Hansen","year":"2004","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113390873700_B24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMp068177","article-title":"Obesity and diabetes in the developing world\u2013a growing challenge","volume":"356","author":"Hossain","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113390873700_B25","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113390873700_B26","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2337\/dc08-0545","article-title":"Translating the A1C assay into estimated average glucose values","volume":"31","author":"Nathan","year":"2008","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113390873700_B27","first-page":"427","article-title":"Update. DCCT Research Group","volume":"13","author":"Diabetes Control and Complications Trial (DCCT)","year":"1990","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113390873700_B28","first-page":"837","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group [published erratum appears in Lancet. 1999;14;35:602]","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113390873700_B29","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1210\/jc.2009-2433","article-title":"Utility of glycated hemoglobin in diagnosing type 2 diabetes mellitus: a community-based study","volume":"95","author":"Kumar","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113390873700_B30","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.2337\/dc08-S055","article-title":"Diagnosis and classification of diabetes mellitus","volume":"31","author":"American Diabetes Association","year":"2008","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113390873700_B31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinte.161.3.397","article-title":"Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria","volume":"161","year":"2001","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113390873700_B32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1464-5491.2007.02043.x","article-title":"The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program","volume":"24","author":"Diabetes Prevention Program Research Group","year":"2007","journal-title":"Diabet Med"},{"key":"key\n\t\t\t\t2019041113390873700_B33","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2337\/diacare.24.8.1448","article-title":"Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy","volume":"24","author":"Singleton","year":"2001","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113390873700_B34","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1093\/eurheartj\/ehq099","article-title":"Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in angiographied coronary patients","volume":"31","author":"Sourij","year":"2010","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019041113390873700_B35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1212\/WNL.60.1.108","article-title":"The spectrum of neuropathy in diabetes and impaired glucose tolerance","volume":"60","author":"Sumner","year":"2003","journal-title":"Neurology"},{"key":"key\n\t\t\t\t2019041113390873700_B36","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/diacare.22.6.920","article-title":"Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study","volume":"22","author":"Tominaga","year":"1999","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113390873700_B37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1365-2567.1997.00120.x","article-title":"Binding of human and rat CD59 to the terminal complement complexes","volume":"90","author":"Lehto","year":"1997","journal-title":"Immunology"},{"key":"key\n\t\t\t\t2019041113390873700_B38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2567.2004.02086.x","article-title":"Glycation of CD59 impairs complement regulation on erythrocytes from diabetic subjects","volume":"114","author":"Davies","year":"2005","journal-title":"Immunology"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/6\/E999\/9050451\/jcemE999.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T09:22:47Z","timestamp":1597569767000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/99\/6\/E999\/2538292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,1]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2013-4232","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,1]]}}}